Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
ATLAS ARTERIA (ALX)ASX AI Signals has generated 2 signal(s) for ALX during the last 90 days, indicating Moderate trading activity
Latest ALX Signals | |
| 16/06/2026 | SELL |
| 02/06/2026 | BUY |
| 06/03/2026 | NEUTRAL |
ALX Share Price | |
| Current Price | $5.100 |
| 52 Week High | $5.110 |
| 52 Week Low: | $4.240 |
| Trading at (% of 52 Week High) | 99.80% |
Atlas Arteria (ASX: ALX) is an Australian company that owns and operates toll roads and transport infrastructure. It manages a portfolio of road assets primarily in Australia and the United States, providing long-term infrastructure services to improve traffic flow and connectivity.
The Industrials sector on the ASX includes companies involved in manufacturing, construction, engineering, and logistics services. It covers a wide range of businesses such as machinery production, infrastructure development, transport services, and equipment maintenance. Many firms in this sector support other industries by providing essential goods, technology, and services. The sector plays a key role in economic development and often reflects trends in building, transportation, and industrial activity.
The SELL recommendation for ATLAS ARTERIA (ALX) is supported by technical indicators suggesting downward momentum and potential overvaluation at the current price of 5.1100. Market conditions and sector-specific risks further justify a cautious stance.
Atlas Arteria Limited's (ASX:ALX) healthy profit numbers didn't contain any surprises for investors. However the statutory profit number doesn't tell the whole story, and we have found some factors which might be of concern to shareholders.
This technology could replace computers: discover the 20 s Key Insights
Institutions' substantial holdings in Atlas Arteria implies that they have significant influence over the company's share price The top 5 shareholders own 55% of the company Insiders have been buying lately
A look at the shareholders of Atlas Arteria Limited (ASX:ALX) can tell us whic Atlas Arteria Limited's (ASX:ALX) robust recent earnings didn't do much to move the stock. However the statutory profit number doesn't tell the whole story, and we have found some factors which might be of concern to shareholders.
See our latest analysis for Atlas Arteria ASX:ALX Earnings and Reven Release Date: February 26, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
Atlas Arteria Ltd (MAQAF) reported solid financial performance for 2024, with proportional revenue up across all businesses and traffic growth of 0. The Australian stock market recently reached new heights with the ASX200 hitting an all-time intra-day high of 8,515 points, while discussions around potential interest rate cuts by the Reserve Bank of Australia have captured investor attention. In this environment, identifying stocks that may be prLatest ATLAS ARTERIA(ALX) News
Atlas Arteria (ASX:ALX) Strong Profits May Be Masking Some Underlying Issues
With 73% institutional ownership, Atlas Arteria Limited (ASX:ALX) is a favorite amongst the big guns
Atlas Arteria's (ASX:ALX) Solid Earnings May Rest On Weak Foundations
Atlas Arteria Ltd (MAQAF) (FY 2024) Earnings Call Highlights: Strong Revenue Growth and ...
3 ASX Stocks That May Be Priced Below Their Estimated Intrinsic Value
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial